CRISPR/Cas9-Based Modeling of JAK2 V617F Mutation in K562 Cells Reveals Enhanced Proliferation and Sensitivity to Therapeutic Agents
基于CRISPR/Cas9技术的JAK2 V617F突变K562细胞建模揭示了细胞增殖增强和对治疗药物的敏感性增加
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26104600
Nilsri, Nungruthai; Mekchaaum, Rujira; Kalasin, Supaporn; Jongjitwimol, Jirapas; Daowtak, Krai
